{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137045490928512.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1007/s11481-006-9025-3"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s11481-006-9025-3.pdf"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/article/10.1007/s11481-006-9025-3/fulltext.html"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s11481-006-9025-3"}}],"dc:title":[{"@value":"Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381137045490928514","@type":"Researcher","foaf:name":[{"@value":"Yuri Persidsky"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137045490928512","@type":"Researcher","foaf:name":[{"@value":"Servio H. Ramirez"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137045490928513","@type":"Researcher","foaf:name":[{"@value":"James Haorah"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137045490928515","@type":"Researcher","foaf:name":[{"@value":"Georgette D. Kanmogne"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"15571890"},{"@type":"EISSN","@value":"15571904"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/15571904"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/15571890"}],"prism:publicationName":[{"@value":"Journal of Neuroimmune Pharmacology"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2006-07-06","prism:volume":"1","prism:number":"3","prism:startingPage":"223","prism:endingPage":"236"},"reviewed":"false","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://link.springer.com/content/pdf/10.1007/s11481-006-9025-3.pdf"},{"@id":"http://link.springer.com/article/10.1007/s11481-006-9025-3/fulltext.html"},{"@id":"http://link.springer.com/content/pdf/10.1007/s11481-006-9025-3"}],"createdAt":"2006-07-07","modifiedAt":"2023-05-08","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050573407753932160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimer’s Disease Mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004230188802560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236794098560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Intraperitoneal Administration of AAV9-shRNA Inhibits Target Gene Expression in the Dorsal Root Ganglia of Neonatal Mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360008373653971328","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Minimal contribution of P-gp on the low brain distribution of naldemedine, a peripherally acting μ-opioid receptor antagonist"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706315341952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Possible Roles of Brain Pericytes in Brain Ischemia and Stroke"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285708370590464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Blockade of AT1 Receptors Protects the Blood-Brain Barrier and Improves Cognition in Dahl Salt-Sensitive Hypertensive Rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182251914624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186384360576","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Extracellular Acidification Activates cAMP Responsive Element Binding Protein via Na+/H+ Exchanger Isoform 1–Mediated Ca\n            <sup>2+</sup>\n            Oscillation in Central Nervous System Pericytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186503773696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Peripherally derived FGF21 promotes remyelination in the central nervous system"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567578736384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Lactose-appended β-cyclodextrin as an effective nanocarrier for brain delivery"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204632657664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Intranasal Ginsenoside Rb1 Targets the Brain and Ameliorates Cerebral Ischemia/Reperfusion Injury in Rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282763075217024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"これからのin vitro血液脳関門モデルを考える―新薬開発で脳内移行性を考慮するための技術展開―"},{"@language":"en","@value":"Consideration for future in vitro BBB models — technical development to investigate the drug delivery to the CNS"},{"@language":"ja-Kana","@value":"コレカラ ノ in vitro ケツエキ ノウ カンモン モデル オ カンガエル : シンヤク カイハツ デ ノウナイ イコウセイ オ コウリョ スル タメ ノ ギジュツ テンカイ"},{"@value":"Consideration for future in vitro BBB models - technical development to investigate the drug delivery to the CNS"}]},{"@id":"https://cir.nii.ac.jp/crid/1390576118542593536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"MPS for Blood Brain Barrier"},{"@language":"ja","@value":"血液脳関門を再現するMPS"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1007/s11481-006-9025-3"},{"@type":"CROSSREF","@value":"10.1002/jnr.22594_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"},{"@type":"CROSSREF","@value":"10.1186/1744-8069-9-36_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"},{"@type":"CROSSREF","@value":"10.1016/j.jneuroim.2014.08.615_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2018.12.002_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"},{"@type":"CROSSREF","@value":"10.1007/s10571-011-9747-5_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"},{"@type":"CROSSREF","@value":"10.1038/ajh.2010.241_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"},{"@type":"CROSSREF","@value":"10.1254/fpj.152.287_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"},{"@type":"CROSSREF","@value":"10.1161/atvbaha.112.254946_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"},{"@type":"CROSSREF","@value":"10.1172/jci94337_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"},{"@type":"CROSSREF","@value":"10.1248/bpb.34.1319_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"},{"@type":"CROSSREF","@value":"10.3233/jad-215318_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"},{"@type":"CROSSREF","@value":"10.1016/j.jconrel.2020.09.043_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"},{"@type":"CROSSREF","@value":"10.1248/yakushi.22-00161-2_references_DOI_QhxV2FV5UuEZ5Cxbl5HjEFkaznG"}]}